GLP-1-Agonists combined with Basal Insulin in the Treatment of Type 2 Diabetes mellitus

被引：0
|
作者：
Pavlicek, V. [1 ]
机构：
[1] Kantonsspital Munsterlingen, Med Klin, CH-8596 Munsterlingen, Switzerland
来源：
DIABETOLOGE | 2014年 / 10卷 / 08期
关键词：
D O I：
10.1007/s11428-014-1317-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：662 / 663
页数：2
相关论文
共 50 条
  • [41] Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
    Bolli, Geremia B.
    Porcellati, Francesca
    Meier, Juris J.
    DIABETES CARE, 2020, 43 (10) : 2333 - 2335
  • [42] Expanded Basal Insulin Options for Type 2 Diabetes Mellitus
    Olin, Jacqueline L.
    Harris, Kira B.
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2017, 13 (03): : 210 - 215
  • [43] Intensification of Basal Insulin Treatment Among Patients with Type 2 Diabetes Mellitus in the Netherlands
    Overbeek, Jetty A.
    Houben, Eline
    Kring, Sofia I.
    Briers, Jonathan
    Beest, Fernie J. A. Penning-van
    Van der Heijden, Amber A. W. A.
    Nijpels, Giel
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 77 - 77
  • [44] INTENSIFICATION OF BASAL INSULIN TREATMENT AMONG PATIENTS WITH DIABETES MELLITUS TYPE 2 IN THE NETHERLANDS
    Overbeek, J.
    Houben, E.
    Kring, S.
    Sommer, J.
    Penning-van Beest, F.
    van der Heijden, A.
    Nijpels, G.
    Herings, R.
    VALUE IN HEALTH, 2015, 18 (07) : A617 - A617
  • [45] Efficacy and Safety of GLP-1 Receptor Agonists Across the Spectrum of Type 2 Diabetes Mellitus
    Leiter, Lawrence A.
    Nauck, Michael A.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (07) : 419 - 435
  • [46] Factors Predicting GLP-1 Receptor Agonists Efficacy in Type 2 Diabetes Mellitus Treatment: A Retrospective Observational Study
    Duvnjak, Lea
    Blaslov, Kristina
    DIABETES, 2016, 65 : A572 - A572
  • [47] Treatment of Type 2 Diabetes mellitus (T2DM): Can GLP-1 Receptor Agonists fill in the gaps?
    Sharma, Smriti
    Bhatia, Vinayak
    CHEMICAL BIOLOGY LETTERS, 2020, 7 (04): : 215 - 224
  • [48] A STEPWISE APPROACH TO INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND BASAL INSULIN TREATMENT FAILURE
    Davidson, Mayer B.
    Raskin, Philip
    Tanenberg, Robert J.
    Vlajnic, Aleksandra
    Hollander, Pricilla
    ENDOCRINE PRACTICE, 2011, 17 (03) : 395 - 403
  • [49] GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents
    Trujillo, Jennifer M.
    Nuffer, Wesley
    PHARMACOTHERAPY, 2014, 34 (11): : 1174 - 1186
  • [50] GLP-1-Rezeptoragonisten — neues Wundermittel zur Behandlung des Diabetes mellitus Typ 2?GLP-1 Receptor Agonists — Miraculous Novel Treatment of Type 2 Diabetes?
    Andreas Sönnichsen
    Zeitschrift für Allgemeinmedizin, 2018, 94 (2): : 54 - 56
12345